ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

ALPN Alpine Immune Sciences Inc

64.65
0.09 (0.14%)
최종 업데이트: 03:32:26
15분 지연
기업명 주식 심볼 시장 주식 타입
Alpine Immune Sciences Inc ALPN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.09 0.14% 64.65 03:32:26
개장가 저가 고가 종가 전일 종가
64.61 64.57 64.69 64.56
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
12/04/202405:27PRNUSKuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to..
11/04/202420:24IHMARKETNEWSCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’..
11/04/202405:15BWAlpine Immune Sciences Shares Updated Clinical Data from..
11/04/202405:01BWVertex Enters Into Agreement to Acquire Alpine Immune..
01/04/202422:00BWAlpine Immune Sciences to Present Updated Clinical Data for..
21/03/202420:45BWAlpine Immune Sciences Presents New Translational Data on..
21/03/202405:30BWAlpine Immune Sciences to Participate in Upcoming H.C...
19/03/202405:05BWAlpine Immune Sciences Provides Corporate Update and Full..
08/03/202406:30BWAlpine Immune Sciences to Report Fourth Quarter and Full..
27/02/202406:30BWAlpine Immune Sciences to Participate in Two Upcoming..
15/02/202406:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202423:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/02/202406:12EDGAR2Form 8-K - Current report
02/02/202406:30BWAlpine Immune Sciences to Participate in Two Upcoming..
23/01/202408:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202408:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202406:45EDGAR2Form 8-K - Current report
05/01/202409:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202409:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202306:23EDGAR2Form 8-K - Current report
22/12/202306:15BWAlpine Immune Sciences Announces Amendment of Acazicolcept..
19/12/202306:30BWAlpine Immune Sciences to Present at the 42nd Annual J.P...
23/11/202300:25EDGAR2Form SC 13D/A - General statement of acquisition of..
21/11/202306:30BWAlpine Immune Sciences to Participate in the Evercore ISI..
15/11/202323:00BWAlpine Immune Sciences Presents New Translational Data on..
15/11/202306:15BWAlpine Immune Sciences Reports Third Quarter 2023 Financial..
13/11/202323:00BWAlpine Immune Sciences Presents New Translational Data on..
07/11/202311:41BWAlpine Immune Sciences Announces Pricing of $150 Million..
07/11/202311:37EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
06/11/202320:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/11/202320:02EDGAR2Form 8-K - Current report
06/11/202320:00BWAlpine Immune Sciences Announces Proposed Public Offering
03/11/202322:00BWAlpine Immune Sciences Presents New Preclinical Data on..
02/11/202322:12EDGAR2Form 8-K - Current report
02/11/202322:00BWAlpine Immune Sciences Presents Initial Clinical Data on..
30/10/202322:00BWAlpine Immune Sciences to Present New Translational Data on..
13/10/202322:05BWAlpine Immune Sciences to Present Initial Clinical Data on..
05/10/202306:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202306:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/10/202321:00BWAlpine Immune Sciences Announces Appointment of Wolfgang..
12/09/202321:30BWAlpine Immune Sciences Presents First Preclinical Data for..
06/09/202305:30BWAlpine Immune Sciences to Participate in Two Upcoming..
05/09/202321:30BWAlpine Immune Sciences to Present First Preclinical Data for..
31/08/202305:30BWAlpine Immune Sciences Announces Initiation of Dosing in 240..
23/08/202305:30BWAlpine Immune Sciences Announces Appointment of M. Christina..
17/08/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
15/08/202305:26EDGAR2Form POS AM - Post-Effective amendments for registration..
15/08/202305:22EDGAR2Form 8-K - Current report
15/08/202305:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

최근 히스토리

Delayed Upgrade Clock